MediConnect (MEDI) ICO classificação e detalhes

ICO

20 de fev. de 2019

3 de abr. de 2019

100% completou

Fundos arrecadados - sem dados

past

Private sale

16 de jan. de 2019

6 de fev. de 2019

100% completou

Fundos arrecadados - sem dados

10 000 000.00 USD

past

Detalhes do token

Ticker

MEDI

Moedas Aceitas

BTC, STRAT

Detalhes da Companhia

País registrado

United Kingdom

detalhes adicionais

KYC

sim

Categorias

Plataforma

Sobre MediConnect

A rede de segurança para pacientes, prescritores, farmácias e fabricantes de medicamentos.

Com todos os órgãos reguladores do setor farmacêutico reconhecendo e preocupados com a crescente questão da prescrição excessiva de medicamentos prescritos on-line, a MediConnect pode oferecer uma solução para esse problema crescente quase imediatamente.

Prescritores & amp; as farmácias que utilizam o MediConnect terão a confiança de que, ao usar nossa solução blockchain, o uso indevido e a prescrição excessiva de medicamentos controlados a possíveis adictos - ndash; quem normalmente compraria on-line para medicação & ndash; será eliminado.

Os pacientes receberão a garantia de que o medicamento que estão sendo prescritos é genuíno e de um fabricante licenciado, prescritor e farmácia que esteja usando uma solução padrão-ouro para ajudar a melhorar seu próprio dever de cuidado.

% name% Roadmap

Q1 2018

Conceived Idea and scoped out requirements of a Prescription Drug Addiction Database.

Q2 2018

Agreed blockchain platform partnership with Stratis.

Q3 2018

Presented idea of a regional trial of East Midlands Pharmacies with newly formed Nottingham Addiction Safeguarding Committee.

Q4 2018

Jason Timms appointed chair of the official Prescription Drug Addiction (PDA) Working Group with the BBFA to tackle over prescribing, drug recalls, counterfeit drug reduction.
Agreed contract start date with ASC Nottingham for Q2 2019 and the onboarding of 2 Pharmacies to MediConnect.
Attended all Chairperson Meeting of the BBFA working groups to look at collaborative opportunities of the PDA on legal, identity, master data, assurance and Cybersecurity working groups.

consulte Mais informação

Q1 2019

ICO Public Sale.
PDA Working Group meeting – Invites to attend to CQC, MHRA, GPhC, LPC, Pharma wholesale and retail industry.

Q2 2019

Commence contract with the ASC to support the Nottingham Trial and UK roll out programme.
Tower Pharmacy & UK Meds will be first 2 Pharmacies on the ASC blockchain solution from MediConnect.
6 other Pharmacies will be integrated, including 1 NHS Hospital outpatient dispensing pharmacy.

Q3 2019

Collaboration with Local Pharmacy Groups and membership committee to inform on pilot and expand reach to 20 further pharmacies in Nottingham, Derby & Leicester.
Partnership with Pharmacy Wholesaler – implementation of drug recall and counterfeit medication system.

Q4 2019

Publish trial research and outcomes – present at PDA meeting to CQC, MHRA. GPhC, LPC and Industry.

Q1 2020

The MediConnect platform will demonstrate an improved duty of care and detection that will see a reduction in pharmacy insurance for Pharmacies.

Q2 2020

Will see the recruitment of 500 UK Pharmacies join MediConnect through the expansion of the ASC membership in the UK.

Q3 2020

Aim for MediConnect to be the Industry standard solution for traceability of drugs for recall and counterfeit medication detection.

Q4 2020

The ASC achieves it’s goal of UK Pharmacies required to be members of the ASC and the MediConnect platform is used by all UK pharmacies